LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas

Ann Diagn Pathol. 2021 Dec:55:151801. doi: 10.1016/j.anndiagpath.2021.151801. Epub 2021 Jul 31.

Abstract

Although pheochromocytomas and paragangliomas (PPGLs) are usual low-grade neoplasms, the metastatic forms of these lesions are associated with high morbidity and mortality. Recent studies have discovered multiple aberrantly expressed long non-coding RNAs (lncRNAs) in cancers that may have regulatory roles in tumor pathogenesis and metastasis; however, the roles of some lncRNAs in PPGLs are still unknown. The expression levels of lncRNAs including metastasis-associated lung adenocarcinoma transcript (MALAT1), prostate cancer antigen 3 (PCA3), and HOX transcript antisense intergenic RNA (HOTAIR) in PPGLs were analyzed by in situ hybridization, using two tissue microarrays (TMAs). The pheochromocytoma (PCC) TMA consisted of normal adrenal medulla (N = 25), non-metastatic PCCs (N = 76) and metastatic PCCs (N = 5) while the paraganglioma (PGL) TMA had 73 non-metastatic PGLs and 5 metastatic PGLs. Immunohistochemical staining was performed on all samples with an anti-SDHB antibody. The correlations between lncRNA expression, loss of SDHB expression and clinical characteristics including tumor progression and disease prognosis were investigated. The expression levels of MALAT1 and PCA3 were significantly elevated (2.5-3.9 folds) in both non-metastatic and metastatic PCCs compared to normal adrenal medulla, although there were no significant differences between the non-metastatic and metastatic neoplasms. In contrast to non-metastatic PGLs, metastatic PGLs had significantly upregulated expression of MALAT1, PCA3, and HOTAIR. SDHB loss was more frequently observed in PGLs (25 of 78), especially in metastatic PGLs (5 of 5), compared to PCCs (2 of 81) and in 0 of 5 metastatic PCCs. Patients with SDHB loss, in contrast to SDHB retained, were younger at diagnosis, had higher rates of tumor recurrence, metastatic disease, and mortality. In addition, PGLs with SDHB loss had significantly increased expression of PCA3 compared to tumors with intact SDHB expression. Our findings suggest that specific lncRNAs may be involved in the SDHx signaling pathways in the tumorigenesis and in the development of PPGL.

Keywords: Paraganglioma; Pheochromocytoma; SDHB; lncRNA.

MeSH terms

  • Carcinogenesis
  • Humans
  • Mutation
  • Neoplasm Recurrence, Local
  • Paraganglioma* / diagnosis
  • Paraganglioma* / genetics
  • Paraganglioma* / metabolism
  • Paraganglioma* / pathology
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / genetics
  • Pheochromocytoma* / metabolism
  • Pheochromocytoma* / pathology
  • Prognosis
  • RNA, Long Noncoding* / analysis
  • RNA, Long Noncoding* / genetics
  • Signal Transduction
  • Succinate Dehydrogenase* / genetics
  • Succinate Dehydrogenase* / metabolism

Substances

  • HOTAIR long untranslated RNA, human
  • RNA, Long Noncoding
  • SDHB protein, human
  • Succinate Dehydrogenase